Minute Insight: Aignostics Completes Raise To Fund AI Pathology Platform
The company has raised €14m to develop its AI-based pathology software which will make diagnosing cancer faster and easier.
You may also be interested in...
Reading Paige’s Playbook For Cancer Diagnostics
Paige CEO Andy Moye talked to Medtech Insight about the company’s current offerings in the prostate and breast cancer markets, as well as its future ambitions and general strategy.
Quanta Raises $245M In Series D, Plans To Expand Into Home-Based Dialysis In US
UK-based Quanta will use the proceeds to ramp up European commercialization and bring its SC+ portable hemodialysis system to US-based acute and chronic care facilities, but ultimately hopes to enter the rising US home-based dialysis market.
Investor Eye: A Licensing-Based Approach May Be Best For Revolutionary IP
Keeping a firm grip on one’s IP is a cornerstone of most innovative businesses. However, Robert Cote, CEO of Cote Capital, believes that if the idea is good enough to keep close, it’s good enough to license out.